510(K) CLEARANCES 75 ▼9RECALLS POSTED 26 ▼13CLASS I 2 ▼4PMA DECISIONS 54 ▲7WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K121231Substantially Equivalent

Ind Drug Home Multi-Panel Test (2-5) Ind Morphine Home Test

Ind Ndiagnostic, Inc., Delta, B.C., CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K121231 is the FDA 510(k) clearance record for IND DRUG HOME MULTI-PANEL TEST (2-5) IND MORPHINE HOME TEST, a class II device, cleared for Ind Ndiagnostic, Inc. on under FDA product code NGT (Saline, Vascular Access Flush). FDA's definition for product code NGT reads: "Enhance the performance of intravascular catheters, to maintain patency of the vascular catheter when it is not in use". FDA records list one 510(k) clearance for Ind Ndiagnostic, Inc. As of , FDA records show no recalls naming K121231.

Clearance record

Decision date
Received
(97 days to decision)
Product code
NGT Saline, Vascular Access Flush
Regulation
21 CFR 880.5200
Device class
Class II
Review panel
General Hospital
Applicant
Ind Ndiagnostic, Inc. 1629 Fosters Way, Delta, B.C., CA
510(k) summary
Statement
Third party review
No

Clearances, product code NGT

Trailing 12 months
1 clearance under product code NGT in the twelve months to October 2026, December 2025 the highest month at 1.
Show the numbers
Monthly 510(k) clearances under FDA product code NGT, trailing twelve months
MonthClearances
November 20250
December 20251
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260